Mar 282017
 

Immunotherapy (Advances in Experimental Medicine and Biology)


In the last decade, immunotherapy has revolutionized the practice of medicine in the field of oncology. This book, Immunotherapy, highlights the immunotherapeutic approaches currently in use and strategies to overcome the associated challenges. As comprehensive knowledge of basic immunology in the context of tumor biology is required to move further along the line of development in translational science, this book provides an overview of the cellular components of the immune system that interact with each other to provide a successful immune response.

Immunotherapy offers promising antitumor activity across multiple cancer types as it does not attack the tumor but primarily revitalizes a suppressed immune system. It is beyond the scope of this book to discuss the immunotherapeutic approaches across the tumor board. However, the book features the role of immune-oncology in acute myeloid leukemia, non-small cell lung cancer, and sarcomas to showcase the recent advances in the management of cancer broadly classified as hematological malignancies, solid tumors, and tumors arising in the connective tissue. The book also discusses alternative formulations and combinatorial approaches to enhance the therapeutic index of these agents.

As immunotherapeutic agents differ significantly from chemotherapeutic agents in response patterns and toxicity profiles, evaluating their safety and efficacy in clinical trials remains a challenge. In this book, we discuss the use of a variety of traditional and new immunotherapy criteria to evaluate response, their inadequacies, and clinical implications. The book also outlines how recent advances in medical imaging technology have the potential to provide high-dimensional data to improve decision support and individualize treatment selection and monitoring. Importantly, the book attempts to increase the awareness to immune related adverse events and the need for aggressive and judicious management of toxicities to improve treatment outcomes in patients on immunotherapy

In short, this book provides a broad understanding of immunotherapy and ways to leverage the immune system to make inroads in the fight against cancer.

List Price: $189.00 USD
New From: $121.03 USD In Stock
Used from: $108.93 USD In Stock

GET IT FREE HERE

http://nitroflare.com/view/B9817442FCF96BA/3319531557.pdf

Share Button
Mar 262017
 

Inflammatory Disorders of the Nervous System: Pathogenesis, Immunology, and Clinical Management (Current Clinical Neurology)


This thoroughly updated edition covers all clinical aspects of neuroinflammation.  The latest developments in pathogenesis  and advances in treatment are provided, along with an understanding of the immune system’s role and interactions between the activated immune cells, cerebral endothelial cells, and other main components of the immune cascade.  Cutting-edge and authoritative, this volume offers practitioners a valuable resource for research and clinical practice.

List Price: $109.00 USD
New From: $91.14 USD In Stock
Used from: $87.10 USD In Stock

GET IT FREE HERE

http://nitroflare.com/view/98AEAAC21D906D9/3319512188.pdf

Share Button
Mar 262017
 

IgG4-Related Disease (Current Topics in Microbiology and Immunology)


Features: IgG4 Related Disease Current Topics in Microbiology and Immunology

This volume focuses on IgG4-related disease (IgG4-RD), a novel clinical entity involving multiple organs and of unknown origin, associated with the abundant infiltration of IgG4-positive cells. It consists of nine chapters written by prominent experts in the field and discusses the disease concept, diagnosis and treatment, as well as recent findings on its pathogenesis and pathophysiology. As such, it offers an invaluable source of information for researchers and clinicians alike.

List Price: $139.00 USD
New From: $89.31 USD In Stock
Used from: $95.97 USD In Stock

GET IT FREE HERE

http://nitroflare.com/view/1D3F5122DF0C826/3319525417.pdf

Share Button
Mar 262017
 

Next-Generation Therapies and Technologies for Immune-Mediated Inflammatory Diseases (Progress in Inflammation Research)


As our understanding of immune mediated chronic inflammatory diseases (IMIDs) grows, it becomes more and more clear that these conditions result from the convergence of a multitude of pathogenic mechanisms whose relative individual contribution is different in different patient subsets.

Promising new technologies have been conceived that address the hypotheses that targeting multiple pathways simultaneously, selectively delivering therapeutics to areas of inflammation and/or resetting the immune system, could take efficacy to new levels. However, we have long waited for the arrival of some of these technologies to the bedside, or even far enough in the drug development process in spite of the initial enthusiasm. Some of the examples covered in this book include bispecific antibodies and genomic medicines, microparticles and targeted delivery of drugs to inflamed vasculature.

Most published reviews and book chapters on novel therapies for inflammatory diseases describe positive attributes of molecules or technologies under investigation and the rationale for developing them into therapeutics. The originality and potential value of this book is not in the description of these targets or technologies from the point of view of their structure or mechanism of action exclusively, but rather, in making an effort to critically address the question of what is needed to move these technologies into the clinic. Has the technology not made it past the preclinical stage and why? Has it already been tested in humans and failed? What are the potential reasons behind those failures? What do experts in each field believe can be done better to increase the probabilities of success?

In addition, the authors address the competitive landscape and summarize clinical studies that have failed in the respective area. They talk about the patient populations that would be required for the successful conduction of a clinical trial to test certain molecules, and they proactively share their views regarding both the potential and the drawbacks of targets or methodologies.

List Price: $189.00 USD
New From: $117.88 USD In Stock
Used from: $149.20 USD In Stock

GET IT FREE HERE

http://nitroflare.com/view/E9CB0CF4A1B8E72/3319422510.pdf

Share Button
Mar 222017
 

GET IT FREE HERE

http://nitroflare.com/view/59BEDCEB42C3F15/Single_Cell_Sequencing_and_Systems_Immunology.pdf

Share Button
Feb 272017
 

GET IT FREE HERE

http://nitroflare.com/view/ECF1AB0CD4A8D48/078178204X.pdf

Share Button
Feb 132017
 

GET IT FREE HERE

Share Button
Jan 152017
 

GET IT FREE HERE

Share Button
Jan 132017
 

GET IT FREE HERE

Share Button
Jan 132017
 

GET IT FREE HERE

Share Button